Author:
Buckley Anne F.,McLendon Roger E.,Wikstrand Carol J.,Bigner Darell D.
Reference49 articles.
1. Allan PM, Carson JA, Harper EI, Asser U, Coakham HB, Brownell B, Hemshead JT (1983) Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int J Cancer 31:592–598
2. Bigner SH, Mark J, Mahaley SM, Bigner DD (1984) Patterns of the early, gross chromosomal changes in malignant human gliomas. Hereditas 101:103–113
3. Bigner SH, Mark J, Mahaley SM, Bullard DE, Mahaley MS, Bigner DD (1986) Chromosomal evolution in malignant human gliomas starts with specific and usually numerical deviations. Cancer Genet Cytogenet 22:121–135
4. Bigner SH, Wong AJ, Mark J, Muhlbaier LH, Kinzler K, Vogelstein B, Bigner DD (1987) Relationship between gene amplification and chromosomal deviations in malignant human gliomas. Cancer Genet Cytogenet 24:163–176
5. Bourdon MA, Wikstrand CJ, Furthmayr H, Matthews TJ, Bigner DD (1983) Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res 43:2796–2805